VSEE HEALTH, INC. (VSEE): Nasdaq/NYSE listing notice — Digital Health Acquisition receives additional Nasdaq delisting notice for failing 400 total shareholders rule

September 28, 2023 (the “September 28, 2023 Letter”) from Nasdaq that the Company’s Securities would be delisted from Nasdaq Global because it has not regained compliance with the Market Value of Listed Securities (“MVLS”) Standard. In connection with the September 29, 2023 Letter, on October 4, 2023, the Company requested a hearing before the Nasdaq hearings panel (the “Hearing”) to appeal the MVLS determination and applied to list its Securities on The Nasdaq Capital Market (“NasdaqCM”). The Hearing is scheduled to be held on November 30, 2023 at 12:00 PM Eastern Time. The Company plans to a

October 9, 2023, Digital Health Acquisition Corp., a Delaware corporation (the “Company”), received an additional letter (the “Letter”) from the staff (the “Staff”) at The Nasdaq Global Market (“Nasdaq Global”) notifying the Company that its not meeting the 400 total shareholders requirement under the Nasdaq Listing Rule 5450(a)(2) serves as an additional basis for delisting the Company’s securities (including the Common Stock, Units and Warrants) (the “Securities”) from Nasdaq Global. As previously reported by the Company on its Current Form on 8-K filed on September 29, 2023, it received a l